13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 55 holding rows worth $246,253,014.
- Accession
- 0001633055-23-000002
- Filer
- CIK 1633055
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 55 entries on the cover page, a total value of $246,253,014 stated on the cover page (in dollars after the unit check, H1), rows summing to $246,253,014 with VALUE read as dollars as filed, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVACARE CORP | 461203AJ0 | NOTE 5.000%11/1 | 56,727,000 | $48,705,802 | dollars as filed | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 90,924 | $21,410,784 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 49,678 | $16,460,309 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 126,003 | $13,980,033 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 168,363 | $13,807,450 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 26,077 | $13,376,719 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 58,896 | $11,440,548 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 141,420 | $9,588,276 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 84,357 | $8,730,106 | dollars as filed | |
| INVACARE CORP | 461203AL5 | NOTE 5.000%11/1 | 10,097,000 | $8,457,651 | dollars as filed | |
| SABRA HEALTH CARE REIT INC COM | 78573L106 | REIT | 436,524 | $5,425,993 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 1,259,544 | $5,353,062 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 243,122 | $4,857,578 | dollars as filed | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 217,209 | $4,693,886 | dollars as filed | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 78,144 | $4,673,793 | dollars as filed | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,777,618 | $4,268,708 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 433,035 | $4,070,529 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 21,034 | $3,485,544 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 21,664 | $3,254,366 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 1,063,953 | $2,989,708 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,733,236 | $2,530,525 | dollars as filed | |
| ZOETIS INC CL A | 98978V103 | Stock | 16,728 | $2,451,488 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 281,895 | $2,277,712 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 40,749 | $2,032,153 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 40,452 | $1,973,653 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 6,761 | $1,719,322 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 3,893 | $1,636,968 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 35,265 | $1,587,278 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 29,967 | $1,583,756 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 6,595 | $1,582,536 | dollars as filed | |
| HEALTHPEAK PROPERTIES INC COM | 42250P103 | REIT | 59,578 | $1,493,620 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 135,994 | $1,384,419 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 6,258 | $1,363,618 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 28,187 | $1,143,265 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 136,382 | $1,125,152 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 30,357 | $1,106,209 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 4,596 | $1,092,239 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 282,935 | $976,126 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 1,589 | $875,046 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 11,264 | $868,792 | dollars as filed | |
| DENTSPLY SIRONA INC | 24906P109 | COM | 22,088 | $703,282 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 17,886 | $682,709 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 16,401 | $572,231 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 11,008 | $561,078 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 30,320 | $515,743 | dollars as filed | |
| ACTINIUM PHARMACEUTICALS | 00507W206 | COM | 45,612 | $485,768 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 36,784 | $468,260 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 70,655 | $451,485 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 21,041 | $410,931 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 13,485 | $332,270 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 21,458 | $307,064 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 124,430 | $286,189 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 33,881 | $285,617 | dollars as filed | |
| OYSTER POINT PHARMA INC | 69242L106 | COMMON STOCK | 19,927 | $222,585 | dollars as filed | |
| ATHENEX INC | 04685N103 | COM | 902,236 | $133,080 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-23-000002 | this filing | 2023-02-14 | acceptance time not in the bulk data set |